Effects of Vitamin D, Epigallocatechin Gallate, Vitamin B6, and D-Chiro-inositol Combination on Uterine Fibroids: a Randomized Controlled Trial
Condition: Leiomyoma, Uterine Interventions: Dietary Supplement: Combination of Epigallocatechin gallate, vitamin D, vitamin B6, and D-Chiro-inositol; Other: Placebo Sponsor: Universita di Verona Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 8, 2022 Category: Research Source Type: clinical trials
Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study)
In this study, we aim to compare topical 1% diclofenac gel with placebo in the prevention of capecitabine-induced HFS.MethodsThis is a randomized, placebo-controlled, double-blind, parallel-group superiority trial: the Diclofenac Topical in Reducing Capecitabine induced HFS (D-TORCH) study. A total of 264 patients with breast and gastrointestinal malignancies will be randomly allocated (stratified by sex and type of therapy [monotherapy or combination regimen with capecitabine]) to receive either 1% topical diclofenac or placebo that will be applied over the palmar and dorsal surface of the hands twice daily whilst taking ...
Source: Trials - May 19, 2022 Category: Research Source Type: clinical trials
Evaluation of Aminobutyric Acid, Glutamic Acid, Calcium, Thiamine, Pyridoxine and Cyanocobalamin as Therapy for Vertigo
Condition: Vertigo Interventions: Drug: Gamma-aminobutyric acid tartarate, glutamic acid, dibasic calcium phosphate, thiamine nitrate, pyridoxine chloride and cyanocobalamin; Drug: Ginger Sponsor: Fundação Educacional Serra dos Órgãos Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 3, 2022 Category: Research Source Type: clinical trials
Single Blind Study of Ergoloid Mesylates, 5-HTP and the Combination in Adult Males With Fragile X Syndrome
Condition: Fragile X Syndrome Interventions: Dietary Supplement: 5-Hydroxytryptophan / Vitamin B6; Drug: Ergoloid Mesylate; Other: Placebo Sponsor: Elizabeth Berry-Kravis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2021 Category: Research Source Type: clinical trials
